A61K 9/2018
Sugars, or sugar alcohols
Official title: {Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates}
A61K9/2018 (Sugars, or sugar alcohols) appears on 3,011 US grants and 6,060 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,011
- Published applications
- 6,060
- Assignees
- 1,973
- Inventors
- 10,418
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 7 | 0 |
| 1989 | 8 | 0 |
| 1990 | 7 | 0 |
| 1991 | 7 | 0 |
| 1992 | 13 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 12 | 0 |
| 1996 | 20 | 0 |
| 1997 | 24 | 0 |
| 1998 | 26 | 0 |
| 1999 | 41 | 0 |
| 2000 | 41 | 0 |
| 2001 | 56 | 23 |
| 2002 | 34 | 68 |
| 2003 | 54 | 115 |
| 2004 | 38 | 149 |
| 2005 | 39 | 145 |
| 2006 | 35 | 155 |
| 2007 | 36 | 184 |
| 2008 | 34 | 174 |
| 2009 | 29 | 188 |
| 2010 | 49 | 229 |
| 2011 | 52 | 219 |
| 2012 | 76 | 195 |
| 2013 | 112 | 230 |
| 2014 | 165 | 283 |
| 2015 | 168 | 332 |
| 2016 | 176 | 306 |
| 2017 | 188 | 321 |
| 2018 | 159 | 267 |
| 2019 | 157 | 291 |
| 2020 | 188 | 319 |
| 2021 | 177 | 299 |
| 2022 | 174 | 359 |
| 2023 | 133 | 296 |
| 2024 | 171 | 303 |
| 2025 | 163 | 307 |
| 2026 | 102 | 303 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tableting of specific polymer stabilizers6 Oct 2026US 12,751,926 B2BASF SE
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- Formulation for oral administration, comprising triazine derivative6 Oct 2026US 12,751,955 B2Shionogi & Co., Ltd.
- Oral formulations and uses thereof29 Sep 2026US 12,746,229 B2Inventisbio Co., Ltd.
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Pharmaceutical oral dosage form of q2038 Oct 2026US 2026/0306411 A1Qurient Co., Ltd.
- Triptolide formulations8 Oct 2026US 2026/0306412 A1Minneamrita Therapeutics LLC
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
- Formulations containing tryptamine derivatives and uses thereof8 Oct 2026US 2026/0306453 A1Psilera Inc.
- Use of milvexian in the treatment and prevention of thrombotic conditions in patients with atrial fibrilation8 Oct 2026US 2026/0306492 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms654US 8,499,966 B2AcelRx Pharmaceuticals, Inc. · 2013
- Extruded orally administrable opioid formulations380US 5,958,452 AEuro-Celtique S. A. · 1999
- Extruded multi-particulates364US 5,965,161 AEuro-Celtique S. A. · 1999
- Controlled release hydrocodone formulations336US 6,733,783 B2Euro-Celtique S. A. · 2004
- Melt-extruded orally administrable opioid formulations299US 6,261,599 B1Euro-Celtique S. A. · 2001